This high dose nusinersen regimen for spinal muscular atrophy includes 50 mg loading doses and 28mg maintenance doses.

Generic dapagliflozin is now approved for adults with type 2 diabetes, though current labeling excludes chronic kidney disease and pediatric use.

During the first two years after switching from protease inhibitors to INSTIs, diabetes risk was higher, but not thereafter.

Pseudocyesis can be distinguished from related phenomena such as delusion of pregnancy (belief in being pregnant with no physical signs or symptoms), simulated pregnancy (a deliberate attempt to ...

Reproductive-aged women with diabetes have lower rates of breast and cervical cancer screening, low rates of preconception counseling.

In this study, researchers aimed to assess guideline-concordant colorectal cancer care to quantify how much variation is ...

AAPA announced new legislation in Maine that will remove physician associate practice barriers to improve health care access.

HealthDay News — The United States is planning new tariffs on some name-brand medicines. The move could affect drug prices and how medicines are made. Officials say tariffs could reach as high as 100% ...

Alongside the approval of Ponlimsi, the FDA is reviewing a BLA for TEV-45779, a biosimilar candidate for Xolair, covering all currently approved indications.

In phase 3 clinical trials, orforglipron was associated with significant reductions in mean percent body weight compared with placebo in patients with and without type 2 diabetes.

Confirmatory ZUMA-2 trial data led to full FDA approval of brexucabtagene autoleucel for patients with relapsed or refractory mantle cell lymphoma.